KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Corrigendum to "Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study" [Eur J Cancer 213 (December) (2024) 115078].

Arun A Azad, Karim Fizazi, Nobuaki Matsubara, Fred Saad, Ugo De Giorgi, Jae Young Joung, Peter C C Fong, Robert J Jones, Stefanie Zschäbitz, Jan Oldenburg, Neal D Shore, Curtis Dunshee, Joan Carles, Andre P Fay, Xun Lin, Liza DeAnnuntis, Nicola Di Santo, Michael A Zielinski, Neeraj Agarwal

Eur J Cancer 232 116106

PMID41259940
PMCID-
DOI10.1016/j.ejca.2025.116106
发表日期2025-11-19
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。